Showing 3511-3520 of 9946 results for "".
Jawline Contouring Treatment with Injectables
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/jawline-contouring-treatment-with-injectables/23647/Use of injectables can produce jaw-dropping results.Taking the Leap Into Private Practice
https://practicaldermatology.com/programs/practical-dermatology/taking-the-leap-into-private-practice/24042/Practice is hard. Private practice is even harder.Best Practices for the 2023 Biologic Coordinator
https://practicaldermatology.com/columns/biologic-coordinator/best-practices-for-the-2023-biologic-coordinator/23839/Tips for preparing for the new year to ensure the needs of biologic patients are being met.New in My Practice: Rx
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rx-1/23395/The Future of Telemedicine in Aesthetics
https://practicaldermatology.com/topics/practice-management/the-future-of-telemedicine-in-aesthetics/21073/What are promises and pitfalls of remote medical consultation and care delivery in aesthetics?AI-based DermGPT Focuses on Improved Clinic Productivity
https://practicaldermatology.com/topics/practice-management/ai-based-dermgpt-focuses-on-improved-clinic-productivity/23990/With Faranak Kamangar, MD; an interview by Heidi W. MooreUV Avoidance: Fostering Adherence in Youth and Adults
https://practicaldermatology.com/topics/skin-cancer-photoprotection/uv-avoidance-fostering-adherence-in-youth-and-adults/23503/With a bit of forethought, dermatologists can help change patient behaviors for the long term.An Introduction to Reflectance Confocal Microscopy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/an-introduction-to-reflectance-confocal-microscopy/23150/With recent advancements, this technology is gaining more use in practice.Galderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoUnify the United with Unity
https://practicaldermatology.com/topics/editorial/unify-united-unity/29187/Neal Bhatia, MD, Reflects on the nature of working together and unifying for the betterment of the dermatology profession.